INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 1 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $57,000 | -54.8% | 113,968 | -50.0% | 0.00% | – |
| Q4 2019 | $126,000 | +4.1% | 227,936 | +100.0% | 0.00% | – |
| Q3 2019 | $121,000 | -10.4% | 113,968 | -2.3% | 0.00% | – |
| Q2 2019 | $135,000 | -60.5% | 116,630 | -34.2% | 0.00% | – |
| Q1 2019 | $342,000 | -56.0% | 177,258 | -47.4% | 0.00% | – |
| Q4 2018 | $778,000 | -15.4% | 336,844 | +149.9% | 0.00% | – |
| Q3 2018 | $920,000 | -18.2% | 134,816 | +182.3% | 0.00% | – |
| Q2 2018 | $1,125,000 | – | 47,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |